ZA859805B - 6-thioxanthine derivatives - Google Patents

6-thioxanthine derivatives

Info

Publication number
ZA859805B
ZA859805B ZA859805A ZA859805A ZA859805B ZA 859805 B ZA859805 B ZA 859805B ZA 859805 A ZA859805 A ZA 859805A ZA 859805 A ZA859805 A ZA 859805A ZA 859805 B ZA859805 B ZA 859805B
Authority
ZA
South Africa
Prior art keywords
ethyl
compounds
thioxanthine derivatives
activity
reduced
Prior art date
Application number
ZA859805A
Other languages
English (en)
Inventor
Peter Hofer
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Publication of ZA859805B publication Critical patent/ZA859805B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/22—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Compositions Of Oxide Ceramics (AREA)
  • Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA859805A 1985-02-07 1985-12-23 6-thioxanthine derivatives ZA859805B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/699,254 US4710503A (en) 1985-02-07 1985-02-07 6-thioxanthine derivatives

Publications (1)

Publication Number Publication Date
ZA859805B true ZA859805B (en) 1986-08-27

Family

ID=24808534

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA859805A ZA859805B (en) 1985-02-07 1985-12-23 6-thioxanthine derivatives

Country Status (16)

Country Link
US (2) US4710503A (xx)
EP (1) EP0191313B1 (xx)
JP (2) JPH0780882B2 (xx)
KR (1) KR930002492B1 (xx)
CN (1) CN1013676B (xx)
AT (1) ATE81858T1 (xx)
AU (1) AU570142B2 (xx)
CA (1) CA1275288C (xx)
DE (1) DE3687007T2 (xx)
DK (1) DK161964C (xx)
FI (1) FI84180C (xx)
IL (1) IL77430A (xx)
IN (1) IN161914B (xx)
NO (1) NO163569C (xx)
NZ (1) NZ214653A (xx)
ZA (1) ZA859805B (xx)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4710503A (en) * 1985-02-07 1987-12-01 Euroceltique S.A. 6-thioxanthine derivatives
GB8618931D0 (en) * 1986-08-02 1986-09-10 Euro Celtique Sa 6-thioxanthines
US5310916A (en) * 1988-07-19 1994-05-10 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Trifunctional agents useful as irreversible inhibitors of A1-adenosine receptors
US5298508A (en) * 1988-07-19 1994-03-29 The United States Of America As Represented By The Department Of Health And Human Services Irreversible inhibitors of adenosine receptors
AU5436790A (en) * 1989-04-19 1990-11-16 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Sulfer-containing xanthine derivatives as adenosin antagonists
EP0423805B1 (en) 1989-10-20 2000-08-23 Kyowa Hakko Kogyo Kabushiki Kaisha Condensed purine derivatives
GB9312853D0 (en) * 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5591776A (en) * 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
US5922751A (en) * 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
JPH10508032A (ja) * 1994-12-13 1998-08-04 ユーロ−セルティーク，エス．エイ． アリールチオキサンチン類
AU4527996A (en) * 1994-12-13 1996-07-03 Euro-Celtique S.A. Trisubstituted thioxanthines
WO1996018400A1 (en) * 1994-12-13 1996-06-20 Euro-Celtique, S.A. Trisubstituted thioxanthines
US6025361A (en) * 1994-12-13 2000-02-15 Euro-Celtique, S.A. Trisubstituted thioxanthines
US6166041A (en) * 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
US6075016A (en) * 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
AU2603197A (en) 1996-04-10 1997-10-29 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The Use of an a1 adenosine receptor agonist to treat cerebral ischaemia
US5864037A (en) * 1996-06-06 1999-01-26 Euro-Celtique, S.A. Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity
US5744473A (en) * 1996-09-16 1998-04-28 Euro-Celtique, S.A. PDE IV inhibitors: "bis-compounds"
AR039385A1 (es) * 2002-04-19 2005-02-16 Astrazeneca Ab Derivados de tioxantina como inhibidores de la mieloperoxidasa
SE0302756D0 (sv) * 2003-10-17 2003-10-17 Astrazeneca Ab Novel Compounds
SE0402591D0 (sv) * 2004-10-25 2004-10-25 Astrazeneca Ab Novel use
MY140748A (en) 2004-12-06 2010-01-15 Astrazeneca Ab Novel pyrrolo [3,2-d] pyrimidin-4-one derivatives and their use in therapy
TW200804383A (en) 2006-06-05 2008-01-16 Astrazeneca Ab New compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE587119A (fr) * 1959-10-22 1960-07-29 May & Baker Ltd Nouveaux dérivés de la thioxanthine, leur préparation et les compositions pharmaceutiques qui les contiennent.
SE8002910L (sv) * 1980-04-18 1981-10-19 Draco Ab 3,8-dialkylxantiner, forfarande for deras framstellning, beredning och metoder for behandling av kronisk obstruktiv luftvegssjukdom och kardiovaskulera sjukdomar
US4710503A (en) * 1985-02-07 1987-12-01 Euroceltique S.A. 6-thioxanthine derivatives
GB8510758D0 (en) * 1985-04-27 1985-06-05 Wellcome Found Compounds
GB8618931D0 (en) * 1986-08-02 1986-09-10 Euro Celtique Sa 6-thioxanthines

Also Published As

Publication number Publication date
JPS61183287A (ja) 1986-08-15
FI860285A0 (fi) 1986-01-21
FI84180C (fi) 1991-10-25
AU570142B2 (en) 1988-03-03
NZ214653A (en) 1988-07-28
JPH0899882A (ja) 1996-04-16
US4820709A (en) 1989-04-11
IN161914B (xx) 1988-02-27
US4710503A (en) 1987-12-01
JP2888273B2 (ja) 1999-05-10
DK33286D0 (da) 1986-01-22
FI84180B (fi) 1991-07-15
KR860006464A (ko) 1986-09-11
JPH0780882B2 (ja) 1995-08-30
DK33286A (da) 1986-08-08
KR930002492B1 (ko) 1993-04-02
NO860424L (no) 1986-08-08
EP0191313B1 (en) 1992-10-28
EP0191313A1 (en) 1986-08-20
FI860285A (fi) 1986-08-08
CN86101050A (zh) 1986-11-12
DK161964C (da) 1992-02-10
DK161964B (da) 1991-09-02
IL77430A (en) 1988-10-31
CA1275288C (en) 1990-10-16
AU5184086A (en) 1986-08-14
NO163569B (no) 1990-03-12
ATE81858T1 (de) 1992-11-15
NO163569C (no) 1990-06-20
CN1013676B (zh) 1991-08-28
DE3687007T2 (de) 1993-06-03
DE3687007D1 (en) 1992-12-03

Similar Documents

Publication Publication Date Title
ZA859805B (en) 6-thioxanthine derivatives
UA7088A1 (uk) Спосіб одержання солі 2-(2-гідроксіетоксі)етіламіна та 3,6-діхлор-2-метоксібензойної кислоти
AU2979789A (en) Gas-phase reaction of 1,1,1-trifluorochloroethane with hydrogen fluoride to produce 1,1,1,2-tetrafluoroethane
ZA85441B (en) 6,6-ethylene-15,16-methylene-3-oxo-17alpha-pregn-4-ene-21,17-carbolactones,processes for the production thereof,and pharmaceutical preparations containing them
IE822064L (en) Composition containing human insulin and c-peptide
AU5516590A (en) Dehydrocholecalciferol derivatives
GR3001691T3 (en) Novel crystalline salts of aryloxy-propanolamines, their preparation and their use
CA1271748C (en) BENZAZEPINE DERIVATIVES
AU575022B2 (en) Antiviral 5-halovinyl-2'-deoxyuridines
PT83267A (en) Novel beta-lactama compounds
EP0187711A3 (en) Octahydroindolizine compounds useful as analgesics
HK1000116A1 (en) Preparation of 3,3- diarylacrylic acid amides
ES2014187A6 (es) Procedimiento para preparar levo y dextro-dropropizina.
ES8707489A1 (es) Un procedimiento para preparar un derivado de carbaciclina
AU2601088A (en) Hypoglycaemic peptides
SU1121940A1 (ru) Этиловый эфир [3-метил-5- 2′ -оксифенил)-1,2,4-триазолил-1] уксусной кислоты, обладающий психостимулирующим действием
ES8707203A1 (es) Procedimiento para purificar una 5-pirimidincarboxamida
YU43402B (en) Process for preparation of 11-aza-10-deoxo-10-dihydroeritromycin "a" by using electro-chemical reduction
SU1167881A1 (ru) Фенилгидразид морфолинодиэтилуксусной кислоты, обладающий противотуберкулезным действием
ES8606271A1 (es) Procedimiento de preparacion de sulfonamidas con agrupacion imido
SU1146989A1 (ru) ГИДРОХЛОРИД ОРТО-БРОМАНИЛИДА β -ДИЭТИЛАМИНОПРОПИОНОВОЙ КИСЛОТЫ, ПРОЯВЛЯЮЩИЙ АНЕСТЕЗИРУЮЩУЮ АКТИВНОСТЬ
UA6324A1 (uk) Спосіб одержання похідних 6-фтор-1, дігідро-4-оксо-7-заміщений піперазінілхінолін-3-карбонової кислоти або їх фармацевтично прийнятних солей